Skip to main content

Select Drug Profiles

Results-driven Healthcare: Addressing the Staggering Cost of Poor Performance

Kip Piper, MA, FACHE

Practice Management

Comparing Pharmacy Benefit Managers: Moving Well Beyond the Simple Spreadsheet Analysis

David Calabrese, RPh, MHP

Stakeholder Perspective

Maximizing Savings, Efficiency, and Quality when Contracting with a PBM

by Thomas McCarter, MD, FACP

Practice Management

Where Generics and Biologics Meet

Melisa J. Heinrichs, PharmD, BSPS, Gary M. Owens, MD

Original Research

Capnography Monitoring Enhances Safety of Postoperative Patient-Controlled Analgesia

Thomas McCarter, MD, FACP, Zakir Shaik, MD, MHA, Keith Scarfo, DO, MS, Laura J. Thompson, RT(R), MBA

Stakeholder Perspective

Capnography in Procedural Anesthesia: At the Edge of a "Perfect Storm"

by Michael F. Murphy, MD, PhD

Conference Highlights AMCP

Looking Down the Pharmaceutical Pipeline

Practice Management

The NCCN Compendium for Cancer Management

Stakeholder Perspective

Economic/Societal Costs of Adding a Compendium to the Federal Registry

by Thomas Kaye, RPh, MBA, FASHP

Risk Factors, Subjectivity, and Truth in Healthcare

Robert E. Henry

Practice Management

Patent Reform Proposals Raise the Stakes for Researchers, Manufacturers of Biologics

Shayna B. Kravetz, BSc, Rosemary Frei, MSc

Stakeholder Perspective

AHDB Stakeholder Perspective

by Thomas McCarter, MD, FACP

Practice Management

The Value of Biologics

Stakeholder Perspective

Value-Based Benefit— A Joint Effort

Original Research

When Novelty Is Not Enough

Michael F. Murphy, MD, PhD

Stakeholder Perspective

AHDB Stakeholder Perspective

Page 231 of 244
Results 2301 - 2310 of 2434